The battle of new biomarkers for right heart failure in pulmonary hypertension: is the queen of hearts NT-proBNP defeated at last?
- PMID: 33795356
- DOI: 10.1183/13993003.04277-2020
The battle of new biomarkers for right heart failure in pulmonary hypertension: is the queen of hearts NT-proBNP defeated at last?
Conflict of interest statement
Conflict of interest: J. van Wezenbeek has nothing to disclose. Conflict of interest: M-J. Goumans has nothing to disclose. Conflict of interest: F.S. de Man has nothing to disclose. Conflict of interest: A. Llucià-Valldeperas has nothing to disclose.
Comment on
-
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension.Eur Respir J. 2021 Apr 1;57(4):1901192. doi: 10.1183/13993003.01192-2019. Print 2021 Apr. Eur Respir J. 2021. PMID: 33184116
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials